Related Experiment Video
Updated: Apr 23, 2026

Comprehensive & Cost Effective Laboratory Monitoring of HIV/AIDS: an African Role Model
Published on: October 31, 2010
Ten best resources for conducting financing and benefit incidence analysis in resource-poor settings
Virginia Wiseman1, Augustine Asante2, Jennifer Price2
1School of Public Health and Community Medicine, University of New South Wales, Samuels Bldg, Kensington Campus, New South Wales 2052, Australia, Department of Global Health and Development, London School of Hygiene and Tropical Medicine, London, UK, Centre for Health Information, Policy and Systems Research, Fiji National University, Suva, Fiji Islands, Faculty of Medicine and Health Sciences, Universudade Nacional Timor-Leste, Díli, Timor-Leste, George Institute for Global Health, University of Sydney, Sydney, Australia School of Public Health and Community Medicine, University of New South Wales, Samuels Bldg, Kensington Campus, New South Wales 2052, Australia, Department of Global Health and Development, London School of Hygiene and Tropical Medicine, London, UK, Centre for Health Information, Policy and Systems Research, Fiji National University, Suva, Fiji Islands, Faculty of Medicine and Health Sciences, Universudade Nacional Timor-Leste, Díli, Timor-Leste, George Institute for Global Health, University of Sydney, Sydney, Australia Virginia.Wiseman@lshtm.ac.uk.
Abstract:
Many low- and middle-income countries are seeking to reform their health financing systems to move towards universal coverage. This typically means that financing is based on people's ability to pay while, for service use, benefits are based on the need for health care. Financing incidence analysis (FIA) and benefit incidence analysis (BIA) are two popular tools used to assess equity in health systems financing and service use. FIA studies examine who pays for the health sector and how these contributions are distributed according to socioeconomic status (SES). BIA determines who benefits from health care spending, with recipients ranked by their relative SES. In this article, we identify 10 resources to assist researchers and policy makers seeking to undertake or interpret findings from financing and benefit incidence analyses in the health sector. The article pays particular attention to the data requirements, computations, methodological challenges and country level experiences with these types of analyses.
Related Concept Videos
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Methods Of Healthcare Delivery System
Managed Care System:
The managed care system is designed to control the cost while maintaining the quality of care. The patient's care from admission to discharge is planned by the primary care provider or the case manager, also known as the gatekeeper. In a managed care system, the number of care providers is...
Prevalence and Incidence
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
Strategies for Assessing and Addressing Confounding
Confounding can be addressed at both the design phase of a study and through analytical methods after data...
Analysis of Population Pharmacokinetic Data
Cancer Survival Analysis

